Envelope surface glycoprotein gp120
|
env
|
Analysis of the distribution of V3 loop's net charge and flexibility in HIV-1 gp120 shows its selection more positive toward CXCR4 than CCR5 |
PubMed
|
|
env
|
CXCR4, a 45kDa cellular membrane protein, interacts with the cell surface HIV-1 gp120-CD4 complex and acts as a coreceptor to preferentially support T cell line-tropic HIV-1 Env-mediated cell fusion and HIV-1 infection |
PubMed
|
|
env
|
The specific amino acids 298-329 in the V3 loop of HIV-1 gp120 that determine cellular tropism also regulate chemokine coreceptor (CCR5 or CXCR4) preference for cell entry by the virus |
PubMed
|
|
env
|
HIV-1 Env (gp120) V3 loop binds to CXCR4 and CCR5 through in silico analysis |
PubMed
|
|
env
|
HIV-1 IIIB Env (gp120) engages CXCR4 and downregulates CHRFAM7A expression in neuronal cells and induces expression of CHRNA7 |
PubMed
|
|
env
|
HIV-1 HXB2 Env (gp120) binds and fuses to CV-1 cells expressing CD4 and CXCR4 |
PubMed
|
|
env
|
HIV-1 gp120 regulates CXCR4 utilization via cooperation between a threonine at gp120 position 123 and a N-glycan at gp120 position 262 without affecting CCR5 utilization |
PubMed
|
|
env
|
HIV-1 gp120 upregulates the level of CXCR4/CCR7 hetero-oligomerization in CD4+ T cells |
PubMed
|
|
env
|
HIV-1 gp120 interacts with CD4 and CXCR4 to enhance CCR7-dependent human CD4+ T cell migration |
PubMed
|
|
env
|
HIV-1 gp120 enhances CCL-21-induced CD4+ T cell chemotaxis in a CXCR4- and CD4-dependent manner |
PubMed
|
|
env
|
A CXCR4 mimetic peptide, which consists of the three extracellular loops of the receptor, binds to HIV-1 gp120 and neutralizes HIV-1 infection |
PubMed
|
|
env
|
The entry of T cell-tropic HIV-1 isolates is blocked by SDF-1 or CXCR4 antagonists, which bind to CXCR4 |
PubMed
|
|
env
|
The coreceptor-binding site in HIV-1 gp120 is centered around an anti-parallel beta-sheet structure 'bridging sheet domain'; mutations in and adjacent to this domain have greater impact on CXCR4-mediated fusion than on CCR5-mediated fusion |
PubMed
|
|
env
|
CCR5 expression inhibits HIV-1 gp120 binding to CD4/CXCR4 complexes in 293T cells |
PubMed
|
|
env
|
CCR5 expression inhibits HIV-1 gp120-mediated early actin rearrangement and -induced LIMK1 activation and cofilin phosphorylation in CD4/CXCR4 expressing 293T cells |
PubMed
|
|
env
|
HIV-1 gp120-enhanced CD4/CXCR4 conformation changes are regulated by CCR5 expression in 293T cells |
PubMed
|
|
env
|
SMS2, but not SMS1, is involved in enhancement of HIV-1 gp120/gp41-mediated membrane fusion through CD4 receptor and CCR5/CXCR4 coreceptors |
PubMed
|
|
env
|
Positively charged Lys/Arg at position 322 in the V3 of gp120 and negatively charged Asp/Glu at position 440 in in the C4 of gp120 occur more frequently in CXCR4-using viruses |
PubMed
|
|
env
|
V1, V2, and V3 domains and N-linked glycosylation sites of HIV-1 gp120 confer coreceptor tropism; loss of an N-linked glycosylation site within V3 has a major influence on the virus switching from CCR5 to CXCR4 tropism in a V3 charge-dependent manner |
PubMed
|
|
env
|
HIV-1 gp120-CXCR4 signaling triggers cofilin activation and actin dynamics, which are important for a post entry process leading to viral nuclear localization |
PubMed
|
|
env
|
The interaction of CXCR4 with HIV-1 gp120 mediates gp120-induced CXCR3 and EMAP2 expression in human lung microvascular endothelial cells |
PubMed
|
|
env
|
HIV-1 gp120 upregulates the expression of chemokine (C-X-C motif) receptor 4 (CXCR4) in human B cells |
PubMed
|
|
env
|
HIV-1 gp120 induces mucus formation through CXCR4 on normal human bronchial epithelial cells |
PubMed
|
|
env
|
Antibodies to specific epitopes of the CCR5 or CXCR4 chemokine receptors inhibit the entry of M-tropic, T-tropic, or dual-tropic HIV-1 into target cells by blocking the interaction of the receptors with the HIV-1 gp120/CD4 complex |
PubMed
|
|
env
|
Gelsolin overexpression impairs HIV-1 gp120-induced cortical F-actin reorganization and capping and gp120-mediated CD4-CCR5 and CD4-CXCR4 redistribution in permissive lymphocytes |
PubMed
|
|
env
|
HIV-1 gp120-induced dephosphorylation of KV2.1 and re-localization of KV2.1 on the soma and proximal dendrites results in disruption of the clustered KV2.1 via activation of CCR5/CXCR4 co-receptors or SDF-1 alpha treatment |
PubMed
|
|
env
|
Stimulating CXCR4 with HIV-1 envelope glycoprotein 120 induces macropinocytosis, which may have implications for the internalization of HIV-1 |
PubMed
|
|
env
|
Amino acid variants at positions 261 and 263 within the gp41-interactive region of gp120 and a variant at position 326 within the gp120 V3 loop are associated with efficient CXCR4-mediated monocyte-derived macrophages (MDM) entry |
PubMed
|
|
env
|
The interaction of HIV-1 gp120 with CXCR4 is inhibited by neutralizing monoclonal antibodies that prevent the interaction of gp120 with CD4 and by antibodies specific for the gp120 V2 and V3 loops |
PubMed
|
|
env
|
HIV-1 gp120-induced synapse loss requires sequential activation of CXCR4, IL-1beta receptor, and NMDA receptor |
PubMed
|
|
env
|
HIV-1 gp120-mediated CXCR4 activation induces upregulation of neuronal nicotinic receptor, alpha-7 |
PubMed
|
|
env
|
HIV-1 gp120 binding to CXCR4 results in cellular proliferation in osteoblast-like cells |
PubMed
|
|
env
|
HIV-1 X4-tropic gp120 upregulates alpha-SMA (ACTA2) and collagen I alpha 1 expression via the ERK1/2 pathway in a CXCR4-dependent manner in activated human hepatic stellate cells |
PubMed
|
|
env
|
Deaminases APOBEC3F- and APOBEC3G-mediated G-to-A mutations in the V3 region of HIV-1 gp120 lead to the co-receptor switch from R5 to X4 strains |
PubMed
|
|
env
|
Adsorption of multivalent gp120-containing HIV-1 virion particles into CD4+ T lymphocytes results in segregation of CD4 and CXCR4 into distinct lipid micro domains |
PubMed
|
|
env
|
Binding of HIV-1 gp120 to CXCR4 induces cell apoptosis through decreased binding of 14-3-3tau to the pro-apoptotic molecule, Bad |
PubMed
|
|
env
|
HIV-1 gp120-induced PI3-kinase activity and calcium mobilization are inhibited by pertussis toxin and blocking antibodies directed against CCR5 and CXCR4, suggesting that this signaling is mediated through these chemokine receptors |
PubMed
|
|
env
|
HIV-1 gp120 and gp41-mediated virus-cell fusion is more dependent on viral core maturation for viruses bearing CXCR4-tropic gp120 than for those bearing CCR5-tropic gp120 |
PubMed
|
|
env
|
HIV-1 gp120 promotes filamin binding to both CD4 and CXCR4 |
PubMed
|
|
env
|
HIV-1 gp120-induced Ca(2+) fluxing is CD4 dependent and coreceptor specific, and is mediated by the CCR5 and CXCR4 coreceptors |
PubMed
|
|
env
|
HIV-1 and gp120 can induce breast cancer cell apoptosis through gp120-CXCR4 interaction without a CD4-induced conformational change of gp120 |
PubMed
|
|
env
|
CCL2 upregulates CXCR4 on resting CD4(+) T cells in a CCR2-dependent mechanism, increases the ability of these cells to be chemoattracted to CXCR4 using gp120 and renders them more permissive to X4-tropic HIV-1 infection |
PubMed
|
|
env
|
Association and clustering of CD4-CXCR4 induced by HIV-1 gp120 requires moesin-mediated anchoring of actin in the plasma membrane |
PubMed
|
|
env
|
The presence of HIV-1 envelope glycoprotein (gp120) in the rat preoptic anterior hypothalamus provokes fever via interaction CXCR4 pathway |
PubMed
|
|
env
|
IgE-FcepsilonRI coaggregation mediated by HIV-1 gp120 accelerates maximal CXCR4 expression and susceptibility to X4 virus by progenitor mast cells (prMCs) |
PubMed
|
|
env
|
HIV-1 gp120 from a T-cell-tropic virus causes CD4-dependent antagonism of CXCR4 response to SDF-1alpha, whereas gp120 from macrophage-tropic viruses causes CD4-dependent antagonism of CCR5 response to MIP-1alpha |
PubMed
|
|
env
|
HIV-1 gp120-induced neuronal cell death involves p38 mitogen-activated protein kinase; both HIV-1 coreceptors, CCR5 and CXCR4, can mediate HIV-1 gp120-induced neurotoxicity |
PubMed
|
|
env
|
Induction of apoptosis in cell cultures through binding of HIV-1 gp120 or gp160 to CXCR4 involves protein kinase C, basic fibroblast growth factor, caspase-3, and the pro-apoptotic molecule Bax |
PubMed
|
|
env
|
CCR5 and CXCR4 coreceptor engagement by HIV-1 gp120 in primary macrophages activates 2 members of the mitogen-activated protein kinase (MAPK) superfamily, c-Jun amino-terminal kinase and p38 MAPK |
PubMed
|
|
env
|
N-glycosylation at N11 of CXCR4 inhibits the binding of CXCR4 to CXCR4- and CCR5-tropic HIV-1 gp120 |
PubMed
|
|
env
|
HIV-1 gp120 binding to CXCR4 induces NADPH oxidase-mediated production of superoxide radicals in neurons, which is involved in the activation of neutral sphingomyelinase |
PubMed
|
|
env
|
Stimulation of neurons with HIV-1 gp120 or the endogenous CXCR4 agonist, SDF-1 alpha, results in inducing p53 activity and expression of the p53 pro-apoptotic target Apaf-1 |
PubMed
|
|
env
|
In T cell lines and peripheral blood mononuclear cells, HIV-1 gp120-induced apoptosis is regulated by CD45 through the induction of CD45 association with the HIV-1 coreceptor CXCR4 |
PubMed
|
|
env
|
Raji-DC-SIGN cells preferentially enhance CXCR4 usage of dual-tropic HIV-1 with higher V3 charges in gp120 |
PubMed
|
|
env
|
Transcription factor E2F1 is necessary for neuronal cell death induced by HIV-1 gp120 via neuronal CXCR4 |
PubMed
|
|
env
|
An HIV-1 gp120 mutant with a deletion of amino acids E61 to S85 in its C1 region exhibits a strong interaction with CXCR4, although CD4 binding is undetectable |
PubMed
|
|
env
|
HIV-1 gp120 inhibits monocyte response to chemokines and activation by chemoattractants by interacting with CD4 and downregulating the cell surface receptor CXCR4 |
PubMed
|
|
env
|
Conversion of Asp-187 to the neutral amino acid Val in the second extracellular loop of CXCR4, which is a coreceptor for dual-tropic and T-tropic strains of HIV-1, unmasked activity with M-tropic gp120 in fusion and infection experiments |
PubMed
|
|
env
|
The death rate of CD8+ T cells by apoptosis, which is induced by HIV-1 gp120 from CXCR4-tropic HIV strains or by the ligand of the chemokine receptor CXCR4 (SDF-1), is increased markedly during HIV infection of peripheral blood mononuclear cells |
PubMed
|
|
env
|
A gp120 protein derived from the HIV-1 IIIB strain utilizes CXCR4 as a primary receptor in the absence of CD4 on T- and B- lymphoid cell lines |
PubMed
|
|
env
|
A synthetic peptide corresponding to amino acid residues 414-434 of HIV-1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R |
PubMed
|
|
env
|
HIV-1 gp120, but not SDF-1alpha, induces rapid tyrosine phosphorylation of src-like kinase p56lck in CD4+ T cells, whereas both gp120 and SDF-1alpha cause phosphorylation of CXCR4 |
PubMed
|
|
env
|
Cathepsin D may induce conformational modification of HIV-1 gp120, allowing direct interaction with the CXCR4 coreceptor and enhancing HIV-1 infectivity and entry into cells |
PubMed
|
|
env
|
HIV-1 gp120 from both CCR5- and CXCR4-tropic HIV-1 strains opens calcium-activated potassium (K(Ca)), chloride, and calcium-permeant nonselective cation channels in macrophages; these signals are mediated by CCR5 and CXCR4 |
PubMed
|
|
env
|
T-tropic HIV-1 gp120s are capable of priming phorbol ester (PMA) induced co-down-modulation of gp120 complexes with tailless CD4 by interacting with CXCR4, whereas M-tropic gp120 are not, even in the presence of CCR5 |
PubMed
|
|
env
|
The cis expression of DC-SIGN on multiple lymphoid cell lines enables more efficient entry and replication of CXCR4-tropic and CCR5/CXCR4 dual-tropic HIV-1 through its binding to the HIV-1 gp120-CD4-CXCR4 complex |
PubMed
|
|
env
|
SDF-1alpha and HIV-1 gp120 induce the appearance of pseudopodia in which CD26 and CXCR4 colocalize |
PubMed
|
|
env
|
Production of the C-X-C chemokine growth-regulated oncogene alpha (GRO-alpha) is markedly stimulated by CXCR4-tropic HIV-1; HIV-1 gp120 engagement of CXCR4 initiates the stimulation of GRO-alpha production, which is blocked by antibodies to CXCR4 |
PubMed
|
|
env
|
Syncytial apoptosis mediated by the fusion of cells expressing HIV-1 gp120 with cells expressing the CD4/CXCR4 receptor/coreceptor complex causes phosphorylation of p53 on serine 15 and Bax upregulation |
PubMed
|
|
env
|
A CD4-independent, CXCR4-tropic HIV-1 isolate directly interacts with CXCR4 through its mutated gp120, and downregulates CXCR4 membrane expression in CD4-positive or -negative cells chronically infected with the strain |
PubMed
|
|
env
|
The proteasome inhibitors, lactacystin and epoxomicin, inhibit SDF-1alpha and gp120 protein-induced down-modulation of CXCR4 in Jurkat cells |
PubMed
|
|
env
|
Kappa-opioid receptor (KOR) agonist treatment of CD4(+) lymphocytes inhibits HIV-1 envelope gp120/41-mediated membrane fusion via downregulation of CXCR4 |
PubMed
|
|
env
|
HIV-1 gp120 interactions with CXCR4 and CCR5 lead to the cross-desensitization of CCR6 and CCR7; this gp120-induced inhibition is strictly dependent on CXCR4 or CCR5 and lipid rafts but not on CD4 or V(H)3-expressing BCR |
PubMed
|
|
env
|
Brain-derived neurotrophic factor (BDNF) prevents HIV-1 gp120-mediated neuronal cell death by reducing the levels of CXC chemokine receptor-4 (CXCR4), a receptor that mediates HIV-1 gp120-induced apoptosis |
PubMed
|
|
env
|
Binding of HIV-1 gp120 to SupT1 lymphoblastoid cells triggers association between CXCR4 and ganglioside GM3 |
PubMed
|
|
env
|
Engagement of the CCR5 and CXCR4 receptors by HIV-1 gp120 induces tyrosine phosphorylation of the protein tyrosine kinase Pyk2 |
PubMed
|
|
env
|
The first (residues 1-39) and third (residues 176-202) extracellular domains of human CXCR4 are required for the functional interaction with HIV-1 gp120; HIV-1 strains have different requirements for their interaction with CXCR4 |
PubMed
|
Envelope surface glycoprotein gp160, precursor
|
env
|
HIV-1 envelope protein gp140 oligomers enter cells by binding to the chemokine receptor CXCR4 |
PubMed
|
|
env
|
HIV-1 Env co-localizes with CXCR4 and downregulates the coreceptor in HIV-1 infected human cells |
PubMed
|
Envelope transmembrane glycoprotein gp41
|
env
|
SMS2, but not SMS1, is involved in enhancement of HIV-1 gp120/gp41-mediated membrane fusion through CD4 receptor and CCR5/CXCR4 coreceptors |
PubMed
|
|
env
|
HIV-1 gp120 and gp41 form a transitional complex with the CD4 receptor and CCR5/CXCR4 coreceptors during virus-cell and cell-cell membrane fusion |
PubMed
|
|
env
|
The engagement of gp120 by CXCR4 in the HIV-1 Env-mediated fusion process results in a quick HIV-1 gp41 six-helix bundle formation |
PubMed
|
|
env
|
Sequences in the gp41 transmembrane (TM) can modulate coreceptor specificity and that Env sequences other than that of V3 may facilitate efficient CXCR4-mediated entry |
PubMed
|
|
env
|
The interactions between HIV-1 gp120/41, CD4 receptor, and CXCR4 result in cell-virus and cell-cell membrane fusion |
PubMed
|
|
env
|
Peptide P5 (residues 628-683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, inhibits HIV-1 envelope mediated cell-cell fusion and infection of PBMCs by both X4- and R5-tropic HIV-1 strains |
PubMed
|
Nef
|
nef
|
HIV-1 NL4-3 Nef downregulates CXCR4; downregulation is dependent on Nef amino acids 66-77, termed the 'secretion modification region' (SMR; 66-70aa) |
PubMed
|
|
nef
|
HIV-1 Nef downregulates the second major HIV-1 coreceptor, CXCR4, from the surface of HIV-infected primary CD4 T lymphocytes with efficiencies comparable to the natural CXCR4 ligand, stromal cell-derived factor-1 alpha |
PubMed
|
|
nef
|
HIV-1 Nef expression from unintegrated HIV-1 DNA downregulates the surface levels of CD4, CCR5, and CXCR4 on T-lymphocytes and monocytes |
PubMed
|
|
nef
|
HIV-1 Nef co-localizes with CXCR4, AIP4, NEDD4, CD63/LAMP-1-positive vesicles, and HRS/VPS27-positive ESCRT-0 structures |
PubMed
|
|
nef
|
The Lys residues (K327/331/333) in the C-terminal tail of CXCR4 and the catalytic Cys830 in the HECT domain of AIP4 are critically required for HIV-1 Nef-mediated downregulation of CXCR4 |
PubMed
|
|
nef
|
HIV-1 Nef dramatically enhances the binding of AIP4 with CXCR4 and alanine substitutions at positions Q297 and N329 of AIP4 eliminate this binding |
PubMed
|
|
nef
|
HIV-1 Nef-mediated CXCR4 downregulation is dependent on ubiquitinylation, which is mediated by the E3 ubiquitin ligase AIP4 |
PubMed
|
|
nef
|
Specific sequences spanning amino-acids 50 to 60 and 170 to 180 in the HIV-1 Nef protein appear to be necessary for Nef-induced apoptosis as well as for physical interaction with CXCR4 receptors |
PubMed
|
|
nef
|
The inhibition of T-cell migration of HIV-1 Nef expressing cells by CD3 stimulation results from the inhibition of surface expression of CXCR4 |
PubMed
|
|
nef
|
HIV-1 Nef significantly upregulates the expression of CXCR4 on the Caco-2 cell surface |
PubMed
|
|
nef
|
The HIV-1 Nef highly conserved valine-glycine-phenylalanine amino acid triplet (VGF) motif, which links the acidic cluster and the proline-rich motif, is important for downregulation of CXCR4 and MHC-I |
PubMed
|
|
nef
|
Disruption of the proline-rich region of HIV-1 Nef inhibits T-cell migration to SDF-1 alpha, suggesting Nef occupies a position in the CXCR4-mediated signaling pathway that is upstream of an SH3-dependent pathway |
PubMed
|
|
nef
|
An intracellular signaling pathway mediated by the binding of SDF-1alpha and CXCR4 is inhibited by Nef in both Jurkat T cells and primary peripheral CD4+ T lymphocytes |
PubMed
|
|
nef
|
HIV-1 Nef-induced increase in monocyte migration may be caused through CXCR4 function |
PubMed
|
|
nef
|
The interaction of HIV-1 Nef with the cell surface receptor CXCR4 induces apoptosis in CD4+ T cells, an effect that can be inhibited with CXCR4 antibodies, as well as the endogenous CXCR4 ligand SDF-1alpha |
PubMed
|
Pr55(Gag)
|
gag
|
HIV-1 Gag co-localizes with CXCR4 in HIV-1 infected CD4 + T cells |
PubMed
|
|
gag
|
Expression of HIV-1 Gag attenuates SDF-1-mediated downregulation of CXCR4. The effect of Gag is dependent on a TSG101 interacting motif within the C-terminal p6 region of Gag |
PubMed
|
Rev
|
rev
|
Rev(34-50) peptide with AAAAC at the C-terminus inhibits HIV-1 replication by antagonism of Rev and the CXCR4 co-receptor |
PubMed
|
Tat
|
tat
|
HIV-1 Tat upregulates CXCR4 expression on lymphocytes, monocytes/macrophages and erythroid cells, indicating a role for Tat in HIV-1 pathogenesis and in promoting the infectivity of HIV-1 |
PubMed
|
|
tat
|
HIV-1 Tat-mediated inhibition of autophagy in bystander macrophages/monocytic cells requires CXCR4, VEGFR1, and beta-integrins |
PubMed
|
|
tat
|
HIV-1 Tat increases CXCL12-induced internalization of CXCR4, and the Tat-mediated CXCR4 internalization requires activity of protein kinase C (zeta) |
PubMed
|
|
tat
|
HIV-1 Tat binds to CXCR4, competes with the natural ligand of CXCR4, SDF-1alpha, and selectively inhibits the entry and replication of X4-tropic HIV-1 in peripheral blood mononuclear cells (PBMCs), indicating a role for Tat in selecting against X4 virus |
PubMed
|
|
tat
|
HIV-1 Tat can inhibit CXCR4-mediated functions by interfering with the chemotactic activity of SDF-1/CXCL12, an effect mediated by Tat amino acids 25-31 |
PubMed
|
Vpu
|
vpu
|
HIV-1 Vpu downregulates the cell surface expression of chemokine (C-X-C motif) receptor 4 (CXCR4, CD184) |
PubMed
|